SPECIFICATION

Pharmaceutical-Oriented Raw Material Parameters

This page defines the technical specification framework for SAFFRON PHARMA® saffron raw material.

All parameters are subject to batch verification.

Botanical Identity

Botanical name: Crocus sativus L.
Propagation method: vegetative (corm division)
Plant part: dried red stigmas

No synthetic additives.
No artificial coloring.
No blending of unidentified origins.

Primary Commercial Format

Whole Red Stigmas — Sargol Category

  • red stigma portion only
  • no yellow or white style fragments
  • intact, non-powdered structure
  • free from visible foreign matter
  • mechanically unaltered

Material must remain visually verifiable.

Physical Parameters

Moisture target: 8–10%
Maximum limit: ≤ 12%

Uniform red coloration
Characteristic aroma
Absence of mold odor
Absence of visible contamination

Material is dried under controlled low-temperature airflow (≤ 40°C).

Analytical Parameters (ISO 3632 Framework)

Target evaluation parameters:

Crocins (E440) — coloring strength
Picrocrocin (E257) — bitterness marker
Safranal (E330) — aromatic compound

Analytical objective: reproducibility across batches.

Peak single-batch values are not prioritized over multi-season consistency.

Safety & Compliance Screening

Each batch may undergo:

Heavy metal analysis
Microbiological panel
Aflatoxin screening
Multi-residue pesticide screening (when required)

Compliance orientation: EU-aligned botanical raw material standards.

Optional Processed Format

Fine Powder — Pharma-Oriented

Available only under:

  • controlled milling protocol
  • contamination prevention measures
  • traceable batch identity
  • analytical verification

Powder format is not standard retail spice powder.
It is produced exclusively for industrial application.

Traceability Architecture

Each batch follows structured identification:

Genetic Line →
Field Zone →
Harvest Date →
Drying Batch →
Moisture Verification →
Laboratory Analysis →
Lot Packaging

Traceability is mandatory for pharmaceutical credibility.

Exclusion Policy

SAFFRON PHARMA® does not supply:

  • anonymous bulk saffron
  • blended unidentified origin material
  • uncontrolled market-sourced lots
  • culinary mass-market packaging

All material originates from validated program structure.

Standardisation Objective

To establish a reproducible pharmaceutical-grade saffron raw material standard based on:

  • validated genetic stability
  • controlled processing
  • analytical verification
  • structured traceability

Scaling follows validation.